Busey Bank’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$736K Sell
9,189
-524
-5% -$43.2K 0.02% 209
2025
Q4
$828K Sell
9,713
-56
-0.6% -$4.6K 0.02% 197
2025
Q3
$760K Sell
9,769
-53
-0.5% -$4.14K 0.02% 202
2025
Q2
$768K Buy
9,822
+2,260
+30% +$169K 0.02% 195
2025
Q1
$548K Sell
7,562
-323
-4% -$23.1K 0.02% 229
2024
Q4
$584K Sell
7,885
-788
-9% -$55.2K 0.02% 218
2024
Q3
$572K Sell
8,673
-165
-2% -$12K 0.02% 228
2024
Q2
$816K Buy
8,838
+165
+2% +$14.6K 0.03% 186
2024
Q1
$829K Hold
8,673
0.03% 187
2023
Q4
$661K Hold
8,673
0.03% 203
2023
Q3
$601K Sell
8,673
-59
-0.7% -$4.74K 0.03% 205
2023
Q2
$824K Sell
8,732
-1,541
-15% -$134K 0.03% 191
2023
Q1
$850K Sell
10,273
-300
-3% -$23.6K 0.04% 190
2022
Q4
$789K Hold
10,573
0.04% 192
2022
Q3
$873K Hold
10,573
0.04% 188
2022
Q2
$1M Sell
10,573
-78
-0.7% -$8.07K 0.05% 183
2022
Q1
$1.25M Hold
10,651
0.05% 181
2021
Q4
$1.38M Buy
10,651
+2,994
+39% +$349K 0.05% 172
2021
Q3
$866K Buy
7,657
+4,833
+171% +$552K 0.03% 201
2021
Q2
$292K Hold
2,824
0.01% 275
2021
Q1
$236K Buy
2,824
+61
+2% +$5.16K 0.01% 300
2020
Q4
$252K Hold
2,763
0.01% 281
2020
Q3
$221K Buy
+2,763
New +$216K 0.01% 297
2020
Q1
Sell
-2,763
Closed -$215K 361
2019
Q4
$215K Hold
2,763
0.01% 316
2019
Q3
$203K Buy
+2,763
New +$194K 0.01% 316
2018
Q4
Sell
-4,692
Closed -$272K 211
2018
Q3
$272K Buy
+4,692
New +$229K 0.03% 177

Other funds holding EW

Busey Bank's EW Position: Q1 2026 in Review

Busey Bank reduced its Edwards Lifesciences (EW) stake by 5.4% in Q1 2026, selling an estimated $43.2K and leaving 9,189 shares worth $736K. The position accounts for 0.02% of the portfolio, ranked #209.

Busey Bank first reported a position in EW in Q3 2018 and has held it in 26 quarters since. The position peaked at $1.38M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Busey Bank held 9,189 shares of Edwards Lifesciences worth $736K as of Q1 2026.
  • Busey Bank sold 524 Edwards Lifesciences shares in Q1 2026, an estimated $43.2K.
  • Edwards Lifesciences made up 0.02% of Busey Bank's portfolio in Q1 2026, its #209 holding.
  • Busey Bank first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 26 quarters since.
  • Busey Bank's Edwards Lifesciences position peaked at $1.38M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.